• Syros Pharmaceuticals focuses on blood cancer pipeline as biotech sector evolves AD HOC NEWS Fri, 03 Jul 2026 20:34:28 GMT
• enterprise value to ebitda forward of syros pharmaceuticals, inc. – otc:syrs TradingView Tue, 30 Jun 2026 05:38:15 GMT
• Enterprise value to EBIT forward of Syros Pharmaceuticals, Inc. – OTC:SYRS TradingView Tue, 30 Jun 2026 04:31:49 GMT
• enterprise value to revenue forward of syros pharmaceuticals, inc. – otc:syrs TradingView Mon, 29 Jun 2026 13:18:37 GMT
• syros pharmaceuticals, inc. actuals & estimates (lse:0lc7) TradingView Fri, 26 Jun 2026 06:20:07 GMT
• syros pharmaceuticals stock - business model in focus after nasdaq delisting Ad-hoc-news.de Sat, 20 Jun 2026 15:16:40 GMT
• syros pharmaceuticals stock (us8719201096): shares fluctuate after recent earnings and oncology pipe AD HOC NEWS Fri, 29 May 2026 07:00:00 GMT
• syros pharmaceuticals inc (otcm:syrs) stock earnings transcripts GuruFocus Thu, 14 May 2026 09:30:54 GMT
• syros pharmaceuticals inc (otcm:syrs) stock price & 30 year financial data GuruFocus Thu, 14 May 2026 09:23:21 GMT
• syros pharmaceuticals stock (us8719201096): latest updates and business overview AD HOC NEWS Thu, 14 May 2026 07:00:00 GMT
• syros pharmaceuticals stock (us8719201096): delisting to otc triggers investor attention AD HOC NEWS Tue, 12 May 2026 07:00:00 GMT
• syros pharmaceuticals stock (us8719201096): is its gene control platform strong enough to unlock bio AD HOC NEWS Tue, 14 Apr 2026 19:55:25 GMT
• quetzal revives syros's shelved asset | apexonco - clinical trials news and analysis Oncology Pipeline Thu, 09 Apr 2026 07:00:00 GMT
• syros pharmaceuticals, inc. (0lc7.l) analyst insights, price targets & recommendations Yahoo! Finance Canada Thu, 02 Apr 2026 14:16:14 GMT
• syros pharmaceuticals (syrs) expected to announce quarterly earnings on wednesday Defense World Thu, 19 Mar 2026 06:27:24 GMT
• syros pharmaceuticals stock (isin: us8719201096) faces pressure amid biotech sector volatility AD HOC NEWS Fri, 13 Mar 2026 07:00:00 GMT
• aktis oncology, clinical-stage radiopharmaceutical oncology, files for nasdaq global select market ipo TradingView Fri, 09 Jan 2026 08:00:00 GMT
• boston-area biotech nido biosciences to shut down after neurological drug trial fails The Business Journals Tue, 30 Dec 2025 08:00:00 GMT
• reviewing vectura group (otcmkts:vegpf) and syros pharmaceuticals (nasdaq:syrs) Defense World Wed, 19 Nov 2025 07:25:22 GMT
• head-to-head review: aerovate therapeutics (nasdaq:avte) vs. syros pharmaceuticals (nasdaq:syrs) Defense World Thu, 06 Nov 2025 06:46:33 GMT
• syros stock dives 92% on failed phase 3 study, possible loan default (update) MSN Tue, 21 Oct 2025 13:28:26 GMT
• syros gets a "win" at last | apexonco - clinical trials news and analysis Oncology Pipeline Fri, 26 Sep 2025 07:32:06 GMT
• myelodysplastic syndrome pipeline analysis, 2025 by delveinsight | novartis, syros pharmaceuticals, curis, ryvu therapeutics, chia... Barchart.com Mon, 01 Sep 2025 07:00:00 GMT
• rege nephro buys tamibarotene-related assets from syros pharmaceuticals MSN Sat, 30 Aug 2025 19:57:50 GMT
• myelodysplastic syndrome pipeline analysis, 2025 by delveinsight | novartis, syros pharmaceuticals, curis, ryvu therapeutics, chia... Barchart.com Sat, 30 Aug 2025 00:52:00 GMT
• rege nephro buys tamibarotene-related assets from syros pharmaceuticals MSN Fri, 29 Aug 2025 19:03:59 GMT
• myelodysplastic syndrome clinical trials, companies, therapeutic assessment, therapies, treatment algorithm, pipeline analysis | n... Barchart.com Mon, 28 Jul 2025 21:34:06 GMT
• analysts set syros pharmaceuticals, inc. (nasdaq:syrs) target price at $3.33 Defense World Sat, 26 Jul 2025 07:00:00 GMT
• myelodysplastic syndrome clinical trials 2025: ema, pdma, fda openPR.com Mon, 21 Jul 2025 16:26:00 GMT
• quetzal therapeutics debuts with expert leadership, high-impact pipeline and $50 million of committed capital The Manila Times Thu, 17 Jul 2025 07:00:00 GMT
• Quetzal Therapeutics Debuts with Expert Leadership, High-Impact Pipeline and $50 Million of Committed Capital Yahoo Finance Wed, 16 Jul 2025 07:00:00 GMT
• myelodysplastic syndrome pipeline insight 2025: spotlighting openPR.com Mon, 14 Jul 2025 18:58:00 GMT
• bronstein, gewirtz and grossman, llc encourages syros pharmaceuticals, inc. (syrs) stockholders to inquire about securities invest... ACCESS Newswire Thu, 03 Jul 2025 16:11:03 GMT
• syros pharmaceuticals(syrs) stock options chain | quotes & news Moomoo Wed, 02 Jul 2025 09:13:41 GMT
• watch: policy direction—where are we now? Life Sciences Intellectual Property Review Mon, 30 Jun 2025 07:00:00 GMT
• syrs news today | why did syros pharmaceuticals stock go up today? MarketBeat Sun, 29 Jun 2025 07:00:00 GMT
• syros pharmaceuticals, inc. (nasdaq:syrs) receives consensus rating of “hold” from brokerages Defense World Thu, 26 Jun 2025 07:00:00 GMT
• levi & korsinsky reminds syros pharmaceuticals investors of the ongoing investigation into potential violations of securities laws... ACCESS Newswire Sat, 07 Jun 2025 21:27:43 GMT
• syros pharmaceuticals, inc. (nasdaq:syrs) receives consensus rating of “hold” from analysts Defense World Sun, 01 Jun 2025 07:52:42 GMT
• SYROS PHARMACEUTICALS Earnings Preview: Recent $SYRS Insider Trading, Hedge Fund Activity, and More Quiver Quantitative Fri, 30 May 2025 07:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) now covered by stocknews.com Defense World Fri, 16 May 2025 07:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) coverage initiated by analysts at stocknews.com Defense World Thu, 08 May 2025 10:39:08 GMT
• syros pharmaceuticals, inc. (nasdaq:syrs) receives consensus recommendation of “hold” from analysts Defense World Wed, 07 May 2025 07:00:00 GMT
• stocknews.com begins coverage on syros pharmaceuticals (nasdaq:syrs) Defense World Fri, 02 May 2025 09:04:36 GMT
• syrs alert: levi & korsinsky reminds investors of an investigation involving possible securities fraud violations by syros pharmac... ACCESS Newswire Sun, 27 Apr 2025 06:11:44 GMT
• shareholders that lost money on syros pharmaceuticals, inc.(syrs) should contact levi & korsinsky about securities fraud investiga... ACCESS Newswire Sun, 27 Apr 2025 03:24:51 GMT
• syrs alert- levi & korsinsky has commenced an investigation on behalf of syros pharmaceuticals, inc. shareholders who lost money ACCESS Newswire Sat, 26 Apr 2025 04:03:54 GMT
• rege nephro buys tamibarotene-related assets from syros pharmaceuticals MSN Wed, 23 Apr 2025 14:36:00 GMT
• stocknews.com initiates coverage on syros pharmaceuticals (nasdaq:syrs) Defense World Tue, 22 Apr 2025 07:00:00 GMT
• bayer opens $44m us expansion; meribel cdmo launches in europe Endpoints News Thu, 17 Apr 2025 07:00:00 GMT
• rege nephro acquires tamibarotene assets from syros pharmaceuticals to advance adpkd program BioPharma APAC Wed, 16 Apr 2025 07:00:00 GMT
• rege nephro buys tamibarotene-related assets from syros pharmaceuticals MSN Wed, 16 Apr 2025 01:58:18 GMT
• rege nephro buys tamibarotene-related assets from syros pharmaceuticals MSN Tue, 15 Apr 2025 11:11:05 GMT
• Rege Nephro Acquires Tamibarotene-Related Assets from Syros Pharmaceuticals for U.S. Clinical Trials PR Newswire Tue, 15 Apr 2025 07:00:00 GMT
• rege nephro acquires key assets from syros pharmaceuticals (syrs GuruFocus Tue, 15 Apr 2025 07:00:00 GMT
• major kidney disease drug acquisition: rege nephro takes over syros' phase 2 asset Stock Titan Tue, 15 Apr 2025 07:00:00 GMT
• syros pharmaceuticals sells tamibarotene assets to rege nephro TipRanks Tue, 15 Apr 2025 07:00:00 GMT
• rege nephro acquires assets from syros pharmaceuticals (syrs) GuruFocus Tue, 15 Apr 2025 07:00:00 GMT
• rege nephro acquires tamibarotene-related assets from syros pharmaceuticals for u.s. clinical trials ChartMill Mon, 14 Apr 2025 07:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) coverage initiated at stocknews.com Defense World Mon, 14 Apr 2025 07:00:00 GMT
• syros pharmaceuticals, inc. (nasdaq:syrs) given average recommendation of “hold” by brokerages Defense World Sat, 12 Apr 2025 07:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) coverage initiated by analysts at stocknews.com Defense World Sun, 06 Apr 2025 07:00:00 GMT
• stocknews.com begins coverage on syros pharmaceuticals (nasdaq:syrs) The AM Reporter Sun, 30 Mar 2025 07:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) coverage initiated at stocknews.com Defense World Sat, 29 Mar 2025 07:00:00 GMT
• syros pharmaceuticals, inc. (nasdaq:syrs) short interest up 345.9% in march Defense World Thu, 27 Mar 2025 07:00:00 GMT
• syrs alert- levi & korsinsky has commenced an investigation on behalf of syros pharmaceuticals, inc. shareholders who lost money ACCESS Newswire Tue, 25 Mar 2025 09:07:34 GMT
• study unravels mystery of cancer-fueling enzyme, which could lead to new therapies Phys.org Tue, 25 Mar 2025 07:00:00 GMT
• syros pharmaceuticals, inc. (nasdaq:syrs) receives $3.33 average pt from brokerages Defense World Fri, 21 Mar 2025 07:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) now covered by stocknews.com Defense World Fri, 21 Mar 2025 06:39:37 GMT
• syros pharmaceuticals, inc. - common stock (nq: syrs FinancialContent Wed, 19 Mar 2025 07:00:00 GMT
• syros pharmaceuticals (syrs) to release earnings on wednesday Defense World Wed, 19 Mar 2025 07:00:00 GMT
• 12 health care stocks moving in tuesday's pre-market session Benzinga Tue, 18 Mar 2025 07:00:00 GMT
• analyze syros pharmaceuticals inc (nasdaq: syrs) before investing. stocksregister.com Mon, 17 Mar 2025 12:34:44 GMT
• syros pharmaceuticals (nasdaq:syrs) now covered by stocknews.com Defense World Thu, 13 Mar 2025 12:02:16 GMT
• finance watch: sutro halves workforce, cuts lead adc and ceo moves on Citeline News & Insights Thu, 13 Mar 2025 07:00:00 GMT
• 12 health care stocks moving in wednesday's after-market session Benzinga Thu, 13 Mar 2025 07:00:00 GMT
• ualbany researchers unlock new capabilities in dna nanostructure self-assembly EurekAlert! Wed, 12 Mar 2025 07:00:00 GMT
• 12 health care stocks moving in wednesday's after-market session Benzinga Wed, 12 Mar 2025 07:00:00 GMT
• 12 health care stocks moving in wednesday's intraday session Benzinga Wed, 12 Mar 2025 07:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) coverage initiated at stocknews.com Defense World Wed, 05 Mar 2025 08:00:00 GMT
• Syros Pharmaceuticals settles debt with Oxford Finance Investing.com Tue, 04 Mar 2025 08:00:00 GMT
• hello bridgebio, farewell syros and achilles | apexonco - clinical trials news and analysis Oncology Pipeline Mon, 03 Mar 2025 08:00:00 GMT
• syros pharmaceuticals, inc. announces management changes -february 28, 2025 at 04:15 pm est Marketscreener.com Sat, 01 Mar 2025 11:57:35 GMT
• Failed Clinical Trial Forces Syros Pharmaceuticals Into Delisting and Wind-Down Operations Stock Titan Fri, 28 Feb 2025 08:00:00 GMT
• syros announces voluntary delisting from nasdaq and sec deregistration Yahoo Finance Fri, 28 Feb 2025 08:00:00 GMT
• syros pharmaceuticals delists from nasdaq amid restructuring TipRanks Fri, 28 Feb 2025 08:00:00 GMT
• syros pharmaceuticals voluntarily delists from nasdaq, deregisters common stock TipRanks Fri, 28 Feb 2025 08:00:00 GMT
• syros pharmaceuticals to delist from nasdaq, deregister common shares -february 28, 2025 at 04:41 pm est Marketscreener.com Fri, 28 Feb 2025 08:00:00 GMT
• syros pharmaceuticals stock hits 52-week low at $0.18 amid steep decline MSN Thu, 27 Feb 2025 04:20:20 GMT
• syros pharmaceuticals (nasdaq:syrs) now covered by stocknews.com Armenian Reporter Wed, 26 Feb 2025 08:00:00 GMT
• syros pharmaceuticals stock plunges to 52-week low of $0.16 by investing.com Investing.com Australia Wed, 26 Feb 2025 08:00:00 GMT
• syros pharmaceuticals, inc. (syrs) investigation: bronstein, gewirtz and grossman, llc encourages shareholders to seek compensatio... ACCESS Newswire Wed, 26 Feb 2025 06:17:09 GMT
• syros pharmaceuticals stock plunges to 52-week low of $0.16 Investing.com Tue, 25 Feb 2025 08:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) now covered by stocknews.com Defense World Tue, 25 Feb 2025 07:36:51 GMT
• syros pharmaceuticals, inc. (nasdaq:syrs) receives $3.33 average price target from analysts Defense World Mon, 24 Feb 2025 08:00:00 GMT
• what did we find about insider trading at syros pharmaceuticals inc (nasdaq: syrs)? Stocks Register Wed, 19 Feb 2025 08:00:00 GMT
• stocknews.com begins coverage on syros pharmaceuticals (nasdaq:syrs) Defense World Mon, 17 Feb 2025 08:00:00 GMT
• shareholders that lost money on syros pharmaceuticals, inc.(syrs) should contact levi & korsinsky about securities fraud investiga... ACCESS Newswire Wed, 12 Feb 2025 10:08:39 GMT
• stocknews.com begins coverage on syros pharmaceuticals (nasdaq:syrs) Defense World Tue, 11 Feb 2025 08:00:00 GMT
• syros pharmaceuticals inc’s market journey: closing weak at 0.17, down -3.99 The Dwinnex Mon, 10 Feb 2025 15:21:17 GMT
• syros pharmaceuticals inc (nasdaq: syrs) now carries a 12-month price target of $5. Marketing Sentinel Sat, 08 Feb 2025 18:00:47 GMT
• bronstein, gewirtz and grossman, llc encourages syros pharmaceuticals, inc. (syrs) investors to inquire about securities investiga... ACCESS Newswire Sat, 08 Feb 2025 03:10:38 GMT
• syros pharmaceuticals inc [nasdaq: syrs] sees increase in stock value Knox Daily Fri, 07 Feb 2025 19:27:36 GMT
• check out syros pharmaceuticals inc (syrs)’s trade data rather than the analysts’ views SETE News Thu, 06 Feb 2025 15:01:48 GMT
• syros pharmaceuticals inc (syrs) stock price and analyst predictions The News Heater Wed, 05 Feb 2025 20:11:53 GMT
• h.c. wainwright upgrades syros pharmaceuticals inc (syrs) to a buy from a neutral Knox Daily Tue, 04 Feb 2025 15:04:36 GMT
• ratio examination: syros pharmaceuticals inc (syrs)’s price-to-cash and price-to-free cash flow The Dwinnex Mon, 03 Feb 2025 17:19:44 GMT
• syros pharmaceuticals (nasdaq:syrs) now covered by stocknews.com Defense World Sat, 01 Feb 2025 08:00:00 GMT
• syros pharmaceuticals stock hits 52-week low at $0.18 amid steep decline MSN Thu, 30 Jan 2025 18:31:05 GMT
• analysts set syros pharmaceuticals, inc. (nasdaq:syrs) price target at $3.33 Defense World Thu, 30 Jan 2025 06:14:33 GMT
• syros pharmaceuticals stock hits 52-week low at $0.18 amid steep decline Investing.com Wed, 29 Jan 2025 08:00:00 GMT
• fulcrum therapeutics (nasdaq:fulc) versus syros pharmaceuticals (nasdaq:syrs) financial analysis Defense World Tue, 28 Jan 2025 08:00:00 GMT
• syros pharmaceuticals inc (nasdaq: syrs) fell -2280.95%, predicting what to expect in the near future Marketing Sentinel Sat, 25 Jan 2025 08:00:00 GMT
Syros Pharmaceuticals, Inc(NASDAQ:SYRS) 
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are SY-1425, a selective retinoic acid receptor alpha agonist, which is in Ph...
Website: http://www.syros.com
Founded: 2011
Full Time Employees: 83
Sector: Healthcare
Industry: Biotechnology